CPA Commends Trade Court for Overturning Biden’s Illegal Solar Tariff Moratorium
Ruling Clears the Way for Retroactive Tariffs on Billions in Illegally Imported Chinese Solar Equipment
Details
New CPA Report Shows Generic Drug Tariffs Will Not Raise Prices for Patients
The findings refute claims by the pharmaceutical lobby that tariffs would harm consumers, and instead underscore the urgent need for strong trade measures to reshore U.S. production of essential medicines.
Congressional Budget Office Confirms Tariff Revenue Will Decrease Deficit by $4 Trillion
The Congressional Budget Office (CBO) upped the ante on their estimate for fiscal deficit reduction last week, all due to higher tariffs that kicked into effect this month. Tariffs are offsetting tax cuts signed into law this summer in the One Big Beautiful Bill (OBBB).
The Price Impact of Generic Drug Tariffs: Why Patients Do Not Bear the Cost
America is dangerously reliant on high-risk foreign suppliers for essential generic drugs, especially APIs concentrated in China and India. That over-reliance has already triggered preventable crises, such as nationwide chemotherapy shortages when a single overseas plant shut down.
CPA: EU Must Reject Aurobindo’s $5.5 Billion Zentiva Takeover
Aurobindo Pharma’s proposed $5.5 billion acquisition of Prague-based Zentiva poses an unacceptable risk to Europe’s and America’s pharmaceutical security. CPA is calling on the European Union (EU), including Czech authorities and European Commission competition regulators, to reject the transaction.
New Report Shows China’s Plan to Dominate the World Space Market, Supported by U.S. Investors
The study details how Beijing is pursuing a program of “space sector capture” to penetrate and control the space sectors of more than 120 countries through agreements with ostensibly private Chinese companies that, in effect, act as fronts for the People’s Liberation Army (PLA).
As “Liberation Day” Tariffs Take Hold, Inflation Could Rise, But It Won’t All Be Due to Tariffs
It’s been three full months of record-high tariffs, and yet rolling 12-month overall inflation came in at 2.7% in July, the same percentage rate as June, according to last week’s Bureau of Labor Statistics (BLS) inflation report. Core inflation (CPI), which excludes food and oil, rose 3.1% in July, up from 2.9% in June.
CPA Celebrates Commerce Department for Successful Completion of First Section 232 ‘Inclusion Round’
The inclusion of these steel products in the Section 232 tariff program will mean more jobs, more Made-in-the-USA, and help provide steady-order volume to our primary steel producers.
CPA Applauds House Introduction of the Bipartisan ‘Secure Trade Act’
The Secure Trade Act codifies the President’s ten-percent universal tariff, and also repeals China’s “Most Favored Nation” (MFN) status.
CPA Supports the ‘USA Act’ to Improve Development of U.S. Standards in Emerging Technologies
Florida Congressman Daniel Webster’s ‘USA Act’, introduced in August, amends the Science portion of the ‘CHIPS & Sciences Act’ to improve U.S. role in standards setting.
